ETOSAFE P TABLET
ETOSAFE P TABLET belongs to the class of medications called ‘analgesics’ used to treat pain associated with chronic (long-term) conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, etc. Osteoarthritis is a degenerative bone disease in which the tissue supporting the joints wears down. Rheumatoid arthritis is a condition in which the immune system attacks its own tissue leading to joint pain and inflammation. Ankylosing spondylitis is the inflammation of the spine and large joints.
ETOSAFE P TABLET contains Etodolac and Paracetamol. Etodolac is a non-steroidal anti-inflammatory drug (NSAID), and Paracetamol is an analgesic. They act by blocking the production of chemical substances called prostaglandins that cause pain, swelling, and inflammation. The inhibition of these substances can cause a decrease in symptoms such as pain, joint stiffness, and tenderness.
You should take this medicine exactly as prescribed by the doctor. The common side-effects of ETOSAFE P TABLET are nausea, vomiting, stomach pain, indigestion, diarrhea, constipation, dizziness, headache, tiredness, rash, ringing in your ears, clay or black-colored stools, and increased heartbeat. These side-effects are usually mild and temporary. However, if any of these side-effects persist or get worse, inform your doctor immediately.
It is not recommended to take ETOSAFE P TABLET if you are allergic to any contents of it. ETOSAFE P TABLET should not be used in patients with a history of ulcers in the stomach or intestine, have had an allergic reaction to NSAIDs have severe liver, kidney, heart failure, and alcoholic liver disease. It is not recommended for use in children, pregnant women, and breastfeeding mothers. It should be used with caution in elderly patients. It is not advised to consume alcohol as it may increase the risk of stomach bleeding. ETOSAFE P TABLET may cause dizziness, so do not drive or operate heavy machinery if you are not fully alert.
Pain associated with Osteoarthritis, Rheumatoid arthritis, and Ankylosing spondylitis, etc.
ETOSAFE P TABLET is used in the treatment of pain, swelling, and inflammation associated with chronic (long-term) conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, etc. It contains Etodolac and Paracetamol. It acts by blocking the production of chemical substances called prostaglandins that cause pain, swelling, and inflammation.
Before taking ETOSAFE P TABLET, inform your doctor if you have high blood pressure, high cholesterol, diabetes, heart disease, heart attack or stroke, blood clot, stomach bleeding, asthma, edema (fluid overload), smoking habit, and liver, kidney disease. Inform your doctor immediately if you cough up or vomit blood or notice black or tarry stools, as it can be a sign of stomach bleeding. ETOSAFE P TABLET increases skin sensitivity to the sun, so avoid prolonged exposure to sunlight, sunlamps, and tanning beds.
Drug-Drug Interactions: ETOSAFE P TABLET may interact with blood thinners (warfarin), medicine that can suppress the immune system (cyclosporine), anticancer agent (methotrexate), an antidepressant (lithium), water pills, a steroid medicine (prednisone), medicines used to treat nausea and vomiting (metoclopramide and domperidone), and medicine used to lower cholesterol levels (cholestyramine).
Drug-Food Interactions: Do not consume alcohol as it may increase the risk of stomach bleeding and liver damage.
Drug-Disease Interactions: ETOSAFE P TABLET should not be used in patients with ulcers in the stomach or intestine who have had an allergic reaction to NSAIDs and have severe liver, kidney, heart failure, and alcoholic liver disease.
Alcohol intake may increase the risk of stomach bleeding and liver damage while using ETOSAFE P TABLET.
ETOSAFE P TABLET may cause toxic effects to the unborn baby or fetus when given to pregnant women. Consult your doctor for further advice.
ETOSAFE P TABLET may pass into breastmilk and cause unwanted effects to the nursing baby. Consult your doctor for further advice.
ETOSAFE P TABLET may cause dizziness. So, you should not drive or operate heavy machinery if you feel dizzy or not fully alert.
ETOSAFE P TABLET should be used with caution in patients with liver diseases. The dose may have to be adjusted by your doctor as required.
ETOSAFE P TABLET should be used with caution in patients with kidney diseases. The dose may have to be adjusted by your doctor as required.
ETOSAFE P TABLET is not recommended for use in children below 12 years of age.
This item is Not Returnable.
Expires on or after - Sep-23
Osteoarthritis: Osteoarthritis is the common type of arthritis in which the cartilage that cushions the bone's ends erodes due to wear and tear over time. Common symptoms are joint pain and stiffness.
Rheumatoid arthritis (RA): Rheumatoid arthritis (RA) is an autoimmune disease in which the immune cells attack the joints and cause bone erosion leading to severe pain and swelling. It may lead to joint deformity if left untreated.
Ankylosing spondylitis: Ankylosing spondylitis is a type of arthritis in which inflammation is seen in the spine and large joints. It led to pain and stiffness in the back and affected joints.
Wanbury Limited , BSEL Techpark, 'B' Wing, 10th Floor, Sector 30-A, Opp. Vashi Railway Station, Vashi, Navi Mumbai - 400703, India.
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.